ARCHIVES

Fifty-Nine CCOP Awards Made; Payline 250, Six Funded as Exceptions

This article is from The Cancer Letter archive.

Vol. 09 No. 21 | May 27, 1983

Download PDF Visit The Full Archive

Related Articles

Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit

March 30, 2012

FDA Working On New Ground Rules For “Adaptive” Clinical Trial Designs.

July 14, 2006

Three Cancer Centers Test Targeted Therapy For Resistant Acute Myelogenous Leukemia

July 26, 2002

In Brief: Fischinger Hints of “New Player” At FCRF; Gigliotti Named Cancer Control Science Director

December 12, 1986

Older Colon Cancer Patients Also Benefit From Chemotherapy, NCCTG Study Finds

October 26, 2001

New Publications

May 4, 1990